A male, aged 34, experiencing complete remission from KMT2A-MLLT1 acute myeloid leukemia, underwent allogeneic peripheral blood stem cell transplantation from his HLA-matched sister, having been conditioned with a combination of busulfan and cyclophosphamide. He was fortunate to escape severe graft-versus-host disease, yet six months after…[Read more]